Author

Ravshan Ataullakhanov

Institution: Institute for Molecular Medicine

Observed institution: Institute for Molecular Medicine

OpenAlex ID: A5143446502

A randomized, placebo-controlled, double blind Phase 1 trial of the Aβ vaccine, AV-1959R, in non-cognitively impaired participants: prelude for secondary preventive therapy in preclinical AD

2026 · Armine Hovakimyan, Hovhannes Madoyan, et al. · Molecular Neurodegeneration

Works count: 1

Citation count:

H-index:

I10-index: